Cargando…
CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma
BACKGROUND: As a significant cause of malignancy mortality, gastric carcinoma (GC) has been well documented to be an often-fatal diagnosis. Despite the limitations of effective therapy, immunotherapy has emerged as a promising therapeutic approach capable of killing cancer cells via the immune syste...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127212/ https://www.ncbi.nlm.nih.gov/pubmed/34001131 http://dx.doi.org/10.1186/s12967-021-02806-5 |